A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial ...

“Identifying individuals at high risk for UTIs allows for more targeted treatment and care strategies, thereby enhancing patient safety.” — Yunlan Jiang, Chengdu University of Traditional Chinese ...

Research at Stanford Medicine suggests that a urine test may. be able to determine which patients will benefit from additional therapy.

“En bloc resection is a potentially superior technique in treating bladder cancer,” Dr Teoh said. “It is important to have a large-scale multicenter randomized trial to investigate whether en bloc ...

Explore surgical options for metastatic bladder cancer, including radical cystectomy and metastasectomy. Learn how surgery can improve survival and quality of life.

MILAN — Photodynamic diagnosis-guided transurethral resection of bladder tumors did not reduce recurrence rates of non–muscle-invasive bladder cancer (NMIBC) in the longer term compared with standard ...

Patients with nonmetastatic node-positive bladder cancer may have similar survival rates whether they underwent treatment with surgery or radical dose radiotherapy. Patients with nonmetastatic ...

Current risk assessment tools for bladder cancer following transurethral resection of the bladder tumor (TURBT) depend on pathological examination of resected tissue, with the consequent intra- and ...